95092-10-7 (N-甲氧基-N-甲基-2-苯基乙酰胺,N-Methoxy-N-methyl-2-phenylacetamide)

CAS号:
95092-10-7
中文名称:
N-甲氧基-N-甲基-2-苯基乙酰胺
英文名称:
N-Methoxy-N-methyl-2-phenylacetamide
分子式:
C10H13NO2
分子量:
179.215722799301

N-甲氧基-N-甲基-2-苯基乙酰胺(95092-10-7)名称与标识符

名称

中文别名:
N-甲氧基-N-甲基-2-苯乙酰胺;N-甲氧基-n-甲基苯乙酰胺;N-甲氧基-N-甲基-苯乙酰胺;N-甲氧基-N-甲基-2-苯基乙酰胺;
英文别名:
Benzeneacetamide, N-methoxy-N-methyl-;N-methoxy-N-methyl-2-phenylacetamide;N-methoxy-N-methylBenzeneacetamide;N-Methoxy-N-methylphenylacetamide;DFLGWAFOSVGKKK-UHFFFAOYSA-N;N-methoxy-N-methyl-benzeneacetamide;N-methyl-N-methoxy-2-phenylacetamide;SY201708;AK402577;N-Methoxy-N-methylbenzeneacetamide (ACI);CS-0061703;MFCD14707542;F19927;AKOS008953172;XH0803;F1903-0165;EN300-213178;VDA09210;95092-10-7;SCHEMBL361027;DA-40182;DTXSID40439552;

标识符

MDL:
MFCD14707542
InChIKey:
DFLGWAFOSVGKKK-UHFFFAOYSA-N
Inchi:
1S/C10H13NO2/c1-11(13-2)10(12)8-9-6-4-3-5-7-9/h3-7H,8H2,1-2H3
SMILES:
O=C(CC1C=CC=CC=1)N(C)OC

N-甲氧基-N-甲基-2-苯基乙酰胺(95092-10-7)物化性质

实验特性

  • 沸点 : 254.0±33.0 ºC (760 Torr),
  • 闪点 : 107.4±25.4 ºC,
  • 溶解度 : 微溶 (3.9 g/L) (25 ºC),
  • 密度 : 1.079±0.06 g/cm3 (20 ºC 760 Torr),

计算特性

  • 精确分子量 : 179.094628657g/mol
  • 氢键供体数量 : 0
  • 氢键受体数量 : 2
  • 可旋转化学键数量 : 3
  • 同位素质量 : 179.094628657g/mol
  • 重原子数量 : 13
  • 复杂度 : 164
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 1.4
  • 拓扑分子极性表面积 : 29.5

N-甲氧基-N-甲基-2-苯基乙酰胺(95092-10-7)推荐厂家 更多厂家(19)

N-甲氧基-N-甲基-2-苯基乙酰胺(95092-10-7)合成路线

合成路线:1 步
反应条件:
参考文献:
Structure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity
Nordqvist, Anneli ; O'Mahony, Gavin; Friden-Saxin, Maria; Fredenwall, Marlene; Hogner, Anders; et al, ChemMedChem, 2017, 12(1), 50-65
合成路线:1 步
反应条件:
参考文献:
Preparation of peptides for treating tumors
, United States, , ,
合成路线:1 步
反应条件:
参考文献:
Assemblies of 1,4-Bis(diarylamino)naphthalenes and Aromatic Amphiphiles: Highly Reducing Photoredox Catalysis in Water
Hyodo, Yuki; Takahashi, Keigo; Chitose, Youhei; Abe, Manabu ; Yoshizawa, Michito; et al, Synlett, 2022, 33(12), 1184-1188
合成路线:1 步
反应条件:
参考文献:
A Unified Strategy for the Synthesis of Difluoromethyl- and Vinylfluoride-Containing Scaffolds
Duchemin, Nicolas; Buccafusca, Roberto; Daumas, Marc; Ferey, Vincent; Arseniyadis, Stellios, Organic Letters, 2019, 21(20), 8205-8210
合成路线:1 步
反应条件:
参考文献:
Sequential C-selective difluoromethylation/Pd-catalyzed decarboxylative protonation: an efficient access to tertiary difluoromethylated Scaffolds
Duchemin, Nicolas; Buccafusca, Roberto; Daumas, Marc; Ferey, Vincent; Arseniyadis, Stellios, ChemRxiv, 2019, 1, 1-8
合成路线:1 步
反应条件:
参考文献:
Preparation of fosamprenavir intermediate (2R,3S)-1,2-epoxy-3-tert-butoxycarbonylamino-4-phenylbutane
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Highly Stereoselective Cyclopropanation of α,β-Unsaturated Carbonyl Compounds with Methyl (Diazoacetoxy)acetate Catalyzed by a Chiral Ruthenium(II) Complex
Chanthamath, Soda; Takaki, Suguru; Shibatomi, Kazutaka; Iwasa, Seiji, Angewandte Chemie, 2013, 52(22), 5818-5821
合成路线:1 步
反应条件:
参考文献:
Enantioselective synthesis of hydantoins by chiral acid-catalysed condensation of glyoxals and ureas
Aryal, Sushant; Hone, Christopher A.; Polson, Matthew I. J.; Foley, Daniel J., Chemical Science, 2023, 14(29), 7905-7912
合成路线:1 步
反应条件:
参考文献:
Stereoselective synthesis of substituted N-heterocycles via sequential cross metathesis-reductive cyclization
Gebauer, Julian; Dewi, Purnama; Blechert, Siegfried, Tetrahedron Letters, 2005, 46(1), 43-46
合成路线:1 步
反应条件:
参考文献:
Stereoselective synthesis of 2-aryl-4-en-1-ols, promising synthons for the preparation of oxygen heterocycles
Boev, V. I.; Moskalenko, A. I.; Belopukhov, S. L.; Nikonova, G. N., Russian Journal of Organic Chemistry, 2017, 53(2), 169-177
合成路线:1 步
反应条件:
参考文献:
3-Alkoxy-1,2-Dioxolanes: Synthesis and Evaluation as Potential Antimalarial Agents
Schiaffo, Charles E.; Rottman, Matthias; Wittlin, Sergio; Dussault, Patrick H., ACS Medicinal Chemistry Letters, 2011, 2(4), 316-319
合成路线:1 步
反应条件:
参考文献:
Preparation method of organic arsenic-based type II pyruvate kinase inhibitor, and its application in inhibiting tumor
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Composition for the treatment of IGF-1R expressing cancer
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of monomethyl auristatin F derivatives and their trastuzumab conjugates for treating cancers
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of humanized anti-human IGF-1R, HER2 and protein Axl antibodies conjugated with drug for treatment of cancer
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of humanized anti-human IGF-1R antibody-drug conjugates for cancer therapy
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Asymmetric photoredox transition-metal catalysis activated by visible light
Huo, Haohua; Shen, Xiaodong; Wang, Chuanyong; Zhang, Lilu; Roese, Philipp; et al, Nature (London, 2014, 515(7525), 100-103
合成路线:1 步
反应条件:
参考文献:
Preparation of derivatives of dolastatin 10 and auristatins as antitumor agents
, France, , ,